Yokohama, Japan

Norimichi Iwase


Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 68(Granted Patents)


Location History:

  • Yokohama, JP (1992 - 1998)
  • Tokyo, JP (2000)
  • Kanagawa, JP (1995 - 2001)

Company Filing History:


Years Active: 1992-2001

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Norimichi Iwase: Innovator in Anticoagulant Research

Introduction

Norimichi Iwase is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anticoagulant compounds. With a total of six patents to his name, Iwase's work has had a notable impact on pharmaceutical innovations.

Latest Patents

Iwase's latest patents include the development of penicillaminamide derivatives. These compounds are represented by a general formula wherein specific groups are defined, such as alkyl and cycloalkyl groups. The compounds exhibit potent inhibitory activity against thrombin, making them useful as anticoagulants. One of his notable inventions is a sulfate derivative of a specific compound that has shown promise in therapeutic applications.

Career Highlights

Throughout his career, Norimichi Iwase has worked with leading companies in the chemical and pharmaceutical industries. He has been associated with Mitsubishi Chemical Corporation and Mitsubishi Kasei Corporation, where he has contributed to various research projects and innovations.

Collaborations

Iwase has collaborated with notable colleagues in his field, including Yoshikuni Tamao and Koichi Sugawara. These collaborations have further enhanced his research and development efforts in medicinal chemistry.

Conclusion

Norimichi Iwase's contributions to the field of anticoagulant research through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence advancements in medicinal chemistry and pharmaceutical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…